News
Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...
In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering will launch this week ...
Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with ...
Regeneron missed Wall Street estimates for first-quarter results on Tuesday, hurt by waning demand for its blockbuster eye ...
You have to watch your diet with MAOIs. However, I eat an avocado every day and frequently have cheddar cheese. I don’t care ...
The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...
As pressure grows to get artificial colors out of the U.S. food supply, the shift may well start at Abby Tampow’s laboratory ...
Inflammation is likely a key player in atherosclerosis and related cardiovascular events, but questions remain about its role ...
Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...
Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers , Ro and LifeMD to sell branded versions of ...
Mauna Loa dark chocolate covered macadamias were recalled due to the "possible presence of undeclared almonds and cashews." ...
Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results